» Articles » PMID: 21097551

Alteration of Nutritional Status at Diagnosis is a Prognostic Factor for Survival of Amyotrophic Lateral Sclerosis Patients

Overview
Date 2010 Nov 25
PMID 21097551
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aims were to analyse changes in nutritional parameters from diagnosis of amyotrophic lateral sclerosis (ALS) to death and to assess their relationships with survival at the time of diagnosis and during follow-up.

Methods: 92 ALS patients were included and clinically assessed every 3 months (ALS functional rating scale, manual muscular testing, forced vital capacity, weight, BMI, percentage weight loss). Bioimpedance was performed to evaluate body composition (fat-free mass, fat mass and hydration status) and phase angle. Survival analyses were performed from diagnosis to death or censoring date using a Cox model.

Results: The evolution of nutritional parameters in ALS patients was marked by significant decreases in weight, BMI, fat-free mass and phase angle, and increased fat mass. The authors identified an adjusted 30% increased risk of death for a 5% decrease from usual weight at time of diagnosis (RR 1.30; 95% CI 1.08 to 1.56). During follow-up, the authors identified adjusted 34% (95% CI 18% to 51%) and 24% (95% CI 13% to 36%) increased risks of death associated with each 5% decrease in usual weight and each unit decrease in usual BMI, respectively (p<0.0001). Malnutrition during the course was related to a shorter survival (p=0.01), and fat mass level was associated with a better outcome (RR 0.90 for each 2.5 kg fat mass increment).

Conclusions: Nutritional parameters of ALS patients worsened during evolution of the disease, and worse nutritional status (at time of diagnosis or during the course) was associated with a higher mortality. This study offers some justification for studying the use of therapeutic nutritional intervention to modify the survival of ALS patients.

Citing Articles

Evidence-Based Nutritional Recommendations for Maintaining or Restoring Nutritional Status in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review.

de Carvalho Vilar M, Coutinho K, de Lima Vale S, Dourado Junior M, de Medeiros G, Piuvezam G Nutrients. 2025; 17(5).

PMID: 40077653 PMC: 11901627. DOI: 10.3390/nu17050782.


Statin Use and Amyotrophic Lateral Sclerosis Survival: A Population-Based Cohort Study.

Vaage A, Holmoy T, Dahl J, Stigum H, Meyer H, Nakken O Eur J Neurol. 2025; 32(3):e70095.

PMID: 40034089 PMC: 11876845. DOI: 10.1111/ene.70095.


Nutritional and Microbiota-Based Approaches in Amyotrophic Lateral Sclerosis: From Prevention to Treatment.

Cuffaro F, Lamminpaa I, Niccolai E, Amedei A Nutrients. 2025; 17(1.

PMID: 39796536 PMC: 11722677. DOI: 10.3390/nu17010102.


Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients.

Apostolo D, Ferreira L, DOnghia D, Vincenzi F, Vercellino N, Perazzi M Mol Neurobiol. 2025; .

PMID: 39762711 DOI: 10.1007/s12035-024-04671-x.


Association Between Early-Life and Premorbid Measurements of Body Composition and Risk of Motor Neuron Disease: A Prospective Cohort Study in the UK Biobank.

Joyce E, Xu S, Ingre C, Potenza R, Seitz C, Yang H Ann Neurol. 2024; 97(2):259-269.

PMID: 39455418 PMC: 11740284. DOI: 10.1002/ana.27109.